CrowdStrike (NASDAQ:CRWD) Upgraded at BTIG Research

CrowdStrike (NASDAQ:CRWD – Get Free Report) was upgraded by investment analysts at BTIG Research from a “neutral” rating to a “buy” rating in a note issued to investors on Tuesday, Marketbeat reports. The firm currently has a $431.00 price objective on the stock. BTIG Research’s price target would suggest a potential upside of 16.04% from […]

Leave a Reply

Your email address will not be published.

Previous post Guggenheim Begins Coverage on Assembly Biosciences (NASDAQ:ASMB)
Next post Robert W. Baird Issues Pessimistic Forecast for Larimar Therapeutics (NASDAQ:LRMR) Stock Price